APOBEC3B不促进Tp53半合子小鼠的肿瘤进展

IF 1.5 Q4 ONCOLOGY
Cancer reports Pub Date : 2025-04-11 DOI:10.1002/cnr2.70189
Yoshihito Horisawa, Tadahiko Matsumoto, June Takeda, Yusuke Tashiro, Ryosuke Nomura, Suguru Takeuchi, Yugo Kawai, Yasuhiro Kazuma, Yoshinobu Konishi, Hiroyuki Yamazaki, Hiroyuki Matsui, Kotaro Shirakawa, Akifumi Takaori-Kondo
{"title":"APOBEC3B不促进Tp53半合子小鼠的肿瘤进展","authors":"Yoshihito Horisawa,&nbsp;Tadahiko Matsumoto,&nbsp;June Takeda,&nbsp;Yusuke Tashiro,&nbsp;Ryosuke Nomura,&nbsp;Suguru Takeuchi,&nbsp;Yugo Kawai,&nbsp;Yasuhiro Kazuma,&nbsp;Yoshinobu Konishi,&nbsp;Hiroyuki Yamazaki,&nbsp;Hiroyuki Matsui,&nbsp;Kotaro Shirakawa,&nbsp;Akifumi Takaori-Kondo","doi":"10.1002/cnr2.70189","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>DNA cytosine deaminase APOBEC3B (A3B) is one of the endogenous sources of somatic mutations in many types of human cancers and is associated with tumor progression rather than tumorigenesis. However, it remains uncertain whether APOBEC3B-induced mutations accelerate tumor progression or not. In this paper, we established a mouse model with A3B overexpression and investigated whether the introduction of A3B overexpression accelerates tumor development in <i>Tp53</i> hemizygous mice.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>We established A3B transgenic mouse by microinjection and selected the mouse which has only one A3B transgene by genomic qPCR and southern blotting using the probe against the transgene. A3B expression was validated by qPCR, immunoblotting, immunohistochemistry and <i>in vitro</i> CDA assays using lysates of this transgenic mouse liver, spleen and bone marrow. We interbreed this transgenic mouse model with CAG-Cre and <i>Tp53</i> knockout mice and observed differences in tumor progression and survival between <i>Tp53</i> hemizygous mice and <i>Tp53</i> homozygous mice irrespective of A3B expression. Finally, comprehensive genomic mutation analysis was done using the developed tumors.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>We established A3B transgenic mouse which has only one transgene. A3B expression and its CDA activity were confirmed in liver cells and tumor tissues of mice overexpressing A3B. <i>Tp53</i> hemizygous mice developed osteosarcomas, spindle and pleomorphic sarcomas, and squamous cell carcinomas, however we did not observe any difference in tumor development between the mice with or without A3B expression. The tumor with A3B expression has more high-VAF mutations than the one without A3B, but these mutations are not APOBEC signature.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>We developed a Cre inducible A3B transgenic mouse model bearing single copy of <i>A3B</i> gene. Although the introduction of A3B overexpression did not accelerate tumor development in <i>Tp53</i> hemizygous mice, our mouse model with A3B overexpression is well-validated and useful for further research.</p>\n </section>\n </div>","PeriodicalId":9440,"journal":{"name":"Cancer reports","volume":"8 4","pages":""},"PeriodicalIF":1.5000,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cnr2.70189","citationCount":"0","resultStr":"{\"title\":\"APOBEC3B Does Not Promote Tumor Progression in Tp53 Hemizygous Mice\",\"authors\":\"Yoshihito Horisawa,&nbsp;Tadahiko Matsumoto,&nbsp;June Takeda,&nbsp;Yusuke Tashiro,&nbsp;Ryosuke Nomura,&nbsp;Suguru Takeuchi,&nbsp;Yugo Kawai,&nbsp;Yasuhiro Kazuma,&nbsp;Yoshinobu Konishi,&nbsp;Hiroyuki Yamazaki,&nbsp;Hiroyuki Matsui,&nbsp;Kotaro Shirakawa,&nbsp;Akifumi Takaori-Kondo\",\"doi\":\"10.1002/cnr2.70189\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>DNA cytosine deaminase APOBEC3B (A3B) is one of the endogenous sources of somatic mutations in many types of human cancers and is associated with tumor progression rather than tumorigenesis. However, it remains uncertain whether APOBEC3B-induced mutations accelerate tumor progression or not. In this paper, we established a mouse model with A3B overexpression and investigated whether the introduction of A3B overexpression accelerates tumor development in <i>Tp53</i> hemizygous mice.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>We established A3B transgenic mouse by microinjection and selected the mouse which has only one A3B transgene by genomic qPCR and southern blotting using the probe against the transgene. A3B expression was validated by qPCR, immunoblotting, immunohistochemistry and <i>in vitro</i> CDA assays using lysates of this transgenic mouse liver, spleen and bone marrow. We interbreed this transgenic mouse model with CAG-Cre and <i>Tp53</i> knockout mice and observed differences in tumor progression and survival between <i>Tp53</i> hemizygous mice and <i>Tp53</i> homozygous mice irrespective of A3B expression. Finally, comprehensive genomic mutation analysis was done using the developed tumors.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>We established A3B transgenic mouse which has only one transgene. A3B expression and its CDA activity were confirmed in liver cells and tumor tissues of mice overexpressing A3B. <i>Tp53</i> hemizygous mice developed osteosarcomas, spindle and pleomorphic sarcomas, and squamous cell carcinomas, however we did not observe any difference in tumor development between the mice with or without A3B expression. The tumor with A3B expression has more high-VAF mutations than the one without A3B, but these mutations are not APOBEC signature.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>We developed a Cre inducible A3B transgenic mouse model bearing single copy of <i>A3B</i> gene. Although the introduction of A3B overexpression did not accelerate tumor development in <i>Tp53</i> hemizygous mice, our mouse model with A3B overexpression is well-validated and useful for further research.</p>\\n </section>\\n </div>\",\"PeriodicalId\":9440,\"journal\":{\"name\":\"Cancer reports\",\"volume\":\"8 4\",\"pages\":\"\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2025-04-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cnr2.70189\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/cnr2.70189\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer reports","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cnr2.70189","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

DNA胞嘧啶脱氨酶APOBEC3B (A3B)是许多类型人类癌症中体细胞突变的内源性来源之一,与肿瘤进展而非肿瘤发生有关。然而,apobec3b诱导的突变是否会加速肿瘤进展仍不确定。本文建立了A3B过表达小鼠模型,研究引入A3B过表达是否会加速Tp53半合子小鼠的肿瘤发展。方法采用显微注射法建立A3B转基因小鼠,采用基因组qPCR和基因探针南方印迹法筛选A3B转基因小鼠。利用该转基因小鼠肝脏、脾脏和骨髓的裂解物,通过qPCR、免疫印迹、免疫组织化学和体外CDA检测验证A3B的表达。我们将这种转基因小鼠模型与CAG-Cre和Tp53敲除小鼠杂交,观察到Tp53半合子小鼠和Tp53纯合子小鼠在肿瘤进展和生存方面的差异,而不考虑A3B的表达。最后,利用发展的肿瘤进行全面的基因组突变分析。结果建立了A3B转基因小鼠。在过表达A3B小鼠的肝细胞和肿瘤组织中证实了A3B的表达及其CDA活性。Tp53半合子小鼠发生骨肉瘤、梭形和多形性肉瘤以及鳞状细胞癌,但我们没有观察到A3B表达小鼠和不表达小鼠之间肿瘤的发展有任何差异。表达A3B的肿瘤比不表达A3B的肿瘤有更多的高vaf突变,但这些突变不是APOBEC的特征。结论建立了Cre诱导的A3B基因单拷贝转基因小鼠模型。虽然引入A3B过表达并没有加速Tp53半合子小鼠的肿瘤发展,但我们的A3B过表达小鼠模型得到了很好的验证,对进一步的研究有用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

APOBEC3B Does Not Promote Tumor Progression in Tp53 Hemizygous Mice

APOBEC3B Does Not Promote Tumor Progression in Tp53 Hemizygous Mice

Background

DNA cytosine deaminase APOBEC3B (A3B) is one of the endogenous sources of somatic mutations in many types of human cancers and is associated with tumor progression rather than tumorigenesis. However, it remains uncertain whether APOBEC3B-induced mutations accelerate tumor progression or not. In this paper, we established a mouse model with A3B overexpression and investigated whether the introduction of A3B overexpression accelerates tumor development in Tp53 hemizygous mice.

Methods

We established A3B transgenic mouse by microinjection and selected the mouse which has only one A3B transgene by genomic qPCR and southern blotting using the probe against the transgene. A3B expression was validated by qPCR, immunoblotting, immunohistochemistry and in vitro CDA assays using lysates of this transgenic mouse liver, spleen and bone marrow. We interbreed this transgenic mouse model with CAG-Cre and Tp53 knockout mice and observed differences in tumor progression and survival between Tp53 hemizygous mice and Tp53 homozygous mice irrespective of A3B expression. Finally, comprehensive genomic mutation analysis was done using the developed tumors.

Results

We established A3B transgenic mouse which has only one transgene. A3B expression and its CDA activity were confirmed in liver cells and tumor tissues of mice overexpressing A3B. Tp53 hemizygous mice developed osteosarcomas, spindle and pleomorphic sarcomas, and squamous cell carcinomas, however we did not observe any difference in tumor development between the mice with or without A3B expression. The tumor with A3B expression has more high-VAF mutations than the one without A3B, but these mutations are not APOBEC signature.

Conclusion

We developed a Cre inducible A3B transgenic mouse model bearing single copy of A3B gene. Although the introduction of A3B overexpression did not accelerate tumor development in Tp53 hemizygous mice, our mouse model with A3B overexpression is well-validated and useful for further research.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Cancer reports
Cancer reports Medicine-Oncology
CiteScore
2.70
自引率
5.90%
发文量
160
审稿时长
17 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信